The RIQAS ToRCH EQA programme is designed to monitor the performance of 12 tests used to detect congenital abnormalities. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.

• Liquid ready-to-use
• 100% human plasma
• Quarterly reporting (5 samples per quarterly distribution)
• Submit results and view reports online via RIQASNet
• Suitable for both quantitative and qualitative methods of analysis

Parameters

• Anti-Toxoplasma IgG
• Anti-Toxoplasma IgM
• Anti-Rubella IgG
• Anti-Rubella IgM
• Anti-CMV IgG
• Anti-CMV IgM
• Anti-HSV1 IgG
• Anti-HSV1 IgM
• Anti-HSV2 IgG
• Anti-HSV2 IgM
• Anti-HSV-1&2 IgG (combined)
• Anti-HSV-1&2 IgM (combined)